Emmaus Life Sciences, Inc. (EMMA) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 474 transactions totaling $3.3M, demonstrating a bullish sentiment with $3.3M in net insider flow. The most recent transaction on Sep 16, 2024 involved a purchase of 20,000 shares valued at $800.
No significant insider buying has been recorded for EMMA in the recent period.
No significant insider selling has been recorded for EMMA in the recent period.
Based on recent SEC filings, insider sentiment for EMMA is bullish with an Insider Alignment Score of 100/100 and a net flow of $3.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Emmaus Life Sciences, Inc. (EMMA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading EMMA stock, having executed 474 transactions in the past 90 days. The most active insider is Yutaka Niihara (Executive), who has made 371 transactions totaling $2.4M.
Get notified when executives and directors at EMMA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | H. Lim Seah | Executive | Purchase | 20,000 | $0.04 | $800 | |
| Feb 29, 2024 | C. Lee Willis | Executive | Purchase | 77,000 | $0.13 | $10.0K | |
| Feb 28, 2024 | C. Lee Willis | Executive | Purchase | 15,000 | $0.12 | $1.8K | |
| Feb 27, 2024 | C. Lee Willis | Executive | Purchase | 10,000 | $0.13 | $1.3K | |
| Feb 26, 2024 | C. Lee Willis | Executive | Purchase | 13,200 | $0.12 | $1.6K | |
| Dec 20, 2023 | H. Lim Seah | Executive | Sale | 32,500 | $0.05 | $1.6K | |
| Dec 15, 2023 | Peu Zen Wei | Executive | Other | 3,760,983 | $0.29 | $1.1M | Large |
| Dec 15, 2023 | H. Lim Seah | Executive | Sale | 6,000 | $0.11 | $660 | |
| Dec 15, 2023 | H. Lim Seah | Executive | Other | 4,447,426 | $0.29 | $1.3M | Large |
| Nov 30, 2023 | C. Lee Willis | Executive | Purchase | 59,400 | $0.12 | $7.1K | |
| Nov 30, 2023 | C. Lee Willis | Executive | Purchase | 7,417 | $0.12 | $890 | |
| Nov 29, 2023 | C. Lee Willis | Executive | Purchase | 36,000 | $0.12 | $4.3K | |
| Nov 29, 2023 | C. Lee Willis | Executive | Purchase | 4,325 | $0.12 | $519 | |
| Nov 28, 2023 | C. Lee Willis | Executive | Purchase | 12,000 | $0.12 | $1.4K | |
| Nov 28, 2023 | C. Lee Willis | Executive | Purchase | 1,470 | $0.12 | $176 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 469 | $3.3M | 58.3% |
Other(J) | 2 | $2.4M | 41.7% |
Sale(S) | 2 | $2.3K | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insiders at Emmaus Life Sciences, Inc. are accumulating shares at an accelerated pace. With 5 insiders making 474 transactions totaling $3.3M in purchases versus $2.3K in sales, the net buying activity of $3.3M signals strong executive confidence. Yutaka Niihara (Executive) leads the buying activity with $2.4M in transactions across all time.